Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization

Molecular Microbiology

Volumn 23, Issue 5, 1997, Pages 979-986

  Wang, Ping ^a   Read, Martin ^a   Sims, Paul F G ^a   Hyde, John E ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROPTEROATE SYNTHASE; FANSIDAR; FOLIC ACID; SYNTHETASE;

ALLELE; ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; GENE MUTATION; HUMAN; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

PLASMODIUM FALCIPARUM;

EID: 0031029877     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.1997.2821646.x     Document Type: Article

References (29)

1. Baker, H., Tenhove, W., Baker, E., and Frank, O. (1994) Vitamin activities in human portal, hepatic and femoral blood after vitamin ingestion. Int J Vit Nutr Res 64: 60-67.
2. Basco, L.K., de Pécoulas, P.E., Wilson, C.M., Le Bras, J., and Mazabraud, A. (1995) Point mutations in the dihydrofolate reductase - thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol 69: 135-138.
3. Bloland, P.B., Lackritz, E.M., Kazembe, P.N., Were, J.B.O., Steketee, R., and Campbell, C.C. (1993) Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficiency and treatment policy in Africa. J Infect Dis 167: 932-937.
4. Braganca, B.M., Aravindakshan, I.A., and Ghanekar, D.S. (1957) Enzymic cleavage of folic acid by extracts from human blood cells. I. Preparation and cofactor requirements of the enzyme system. Biochim Biophys Acta 25: 623-634.
5. Brooks, D.R., Wang, P., Read, M., Watkins, W.M., Sims, P.F.G., and Hyde, J.E. (1994) Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 224: 397-405.
6. Bzik, D.J., Li, W-B., Horii, T., and Inselburg, J. (1987) Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase - thymidylate synthase gene. Proc Natl Acad Sci USA 84: 8360-8364.
7. Chanarin, I. (1980) The folates. In Vitamins in Medicine. Vol. 1. Barker, B.M., and Bender, D.A. (eds). London: Heinemann Medical Books, pp. 247-314.
8. 3H]hypoxanthine incorporation. Exp Parasitol 55: 138-146.
9. Chulay, J.D., Watkins, W.M., and Sixsmith, D.G. (1984) Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. Am J Trop Med Hyg 33: 325-330.
10. Dieckmann, A., and Jung, A. (1986) Mechanisms of sulfadoxine resistance in Plasmodium falciparum. Mol Biochem Parasitol 19: 143-147.
11. Ferone, R. (1977) Folate metabolism in malaria. Bull WHO 55: 291-298.
12. Ferone, R., and Hitchings, G.H. (1966) Folate cofactor biosynthesis by Plasmodium berghei. Comparison of folate and dihydrofolate as substrates. J Protozool 13: 504-506.
13. Foster, S.D. (1991) Pricing, distribution, and use of antimalarial drugs. Bull WHO 69: 349-363.
14. van Hensbroek, M.B., Morris-Jones, S., Meisner, S., Jaffar, S., Bayo, L., Dackour, R., Phillips, C., and Greenwood, B.M. (1995) Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Trans Roy Soc Trop Med Hyg 89: 672-676.
15. Hyde, J.E. (1990) The dihydrofolate reductase - thymidylate synthase gene in the drug resistance of malaria parasites. Pharmacol Therap 48: 45-59.
16. Krungkrai, J., Webster, H.K., and Yuthavong, Y. (1989) De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 32: 25-38.
17. Milhous, W.K., Weatherly, N.F., Bowdre, J.H., and Desjardins, R.E. (1985) In vitro activities of and mechanisms of resistance to antifol antimalarial drugs. Antimicrob Agents Chemother 27: 525-530.
18. Peterson, D.S., Di Santi, S.M., Povoa, M., Calvosa, V.S., Do Rosario, V.E., and Wellems, T.E. (1991) High incidence of Asn-108 mutations in dihydrofolate reductase as the basis for pyrimethamine resistant falciparum malaria in the Brazilian Amazon. Am J Trop Med Hyg 45: 492-497.
19. Poe, M. (1973) Dihydrofolate reductase from a methotrexateresistant strain of Escherichia coli: dihydrofolate monooxygenase activity. Biochem Biophys Res Commun 54: 1008-1014.
20. Read, M., and Hyde, J.E. (1993) Simple in vitro cultivation of the malaria parasite Plasmodium falciparum (erythrocytic stages) suitable for large-scale preparations. In Protocols in Molecular Parasitology. Hyde, J.E. (ed.). Totowa: Humana Press, pp. 43-56.
21. Schapira, A., Bygbjerg, I.C., Jepsen., S., Flachs, H., and Bentzon, M.W. (1986) The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine-correlation of in vivo and in vitro results. Am J Trop Med Hyg 35: 239-245.
22. Triglia, T., and Cowman, A.F. (1994) Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 91: 7149-7153.
23. Walker-Jonah, A., Dolan, S.A., Gwadz, R.W., Panton, L.J., and Wellems, T.E. (1992) An RFLP map of the Plasmodium falciparum genome, recombination rates and favored linkage groups in a genetic cross. Mol Biochem Parasitol 51: 313-320.
24. Wang, P., Brooks, D.R., Sims, P.F.G., and Hyde, J.E. (1995) A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Mol Biochem Parasitol 71: 115-125.
25. Watkins, W.M., Sixsmith, D.G., Chulay, J.D., and Spencer, H.C. (1985) Antagonism of sulfadoxine and pyrimethamine antimalarial activities in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. Mol Biochem Parasitol 14: 55-61.
26. Watkins, W.M., Howells, R.E., Brandling-Bennett, A.D., and Koech, D.K. (1987) In vitro susceptibility of Plasmodium falciparum isolates from Jilore, Kenya to antimalarial drugs. Am J Trop Med Hyg 37: 445-451.
27. Weidekamm, E., Plozza-Notterbrock, H., Forgo, I., and Dubach, U.C. (1982) Plasma concentrations of pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. Bull WHO 60: 116-122.
28. Wellems, T.E., Panton, L.J., Gluzman, I.Y., do Rosario, V.E., Gwadz, R.W., Walker-Jonah, A., and Krogstad, D.J. (1990) Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345: 253-255.
29. Wu, Y.M., Kirkman, L.A., and Wellems, T.E. (1996) Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Proc Natl Acad Sci USA 93: 1130-1134.